Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
NCT01072357
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Corneal Neovascularization
Corneal Graft Failure
Interventions
DRUG:
Avastin® (bevacizumab)
DRUG:
0.9% NaCl & Refresh Liquigel
Sponsor
Reza Dana, MD